An integrated high-throughput strategy for discovering and validating productive genomic integration hotspots in CHO cells
Frontiers in Bioengineering and Biotechnology · 16.11.2026 · 14
DOI: 10.3389/fbioe.2026.2005695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 16.11.2026. Verfasst von Yonghui Sun und 10 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chinese Hamster Ovary (CHO) cells have long served as the primary workhorse of the biopharmaceutical industry. Conventional cell line development relies on random integration methods, which require multiple rounds of selection pressure and clonal verification to isolate monoclonal cell lines with the highest productivity. However, this approach often results in significant clonal variation and poor expression stability, thereby necessitating labor-intensive screening. To address the limitations mentioned above, site-specific integration of a protein expression cassette into predefined chromosomal loci exhibiting high expression and stability has emerged as a promising strategy. In this study, we established a high-throughput method for the detection and analysis of insertion sites to identify genomic “hotspot” loci from a stable, high-expression cell library generated via lentiviral random integration. Among 5,474 candidate integration loci, 12 candidate hotspot loci, together with four previously reported loci, were selected for validation of monoclonal antibody expression using a CRISPR/Cas9-mediated site-specific integration system. In parallel, we developed an Auto-MCS platform for CHO cell line development that enables the simultaneous screening of hundreds of monoclonal cells, thereby facilitating the efficient generation and characterization of site-specifically integrated monoclonal cell lines. Comparative evaluation of clones carrying different integration loci in 24-deep-well plates identified four newly discovered hotspots with 1.55- to 3.22-fold higher relative specific productivity than the previously reported reference locus NW_003626341.1. Shake-flask evaluation was subsequently performed on three clones from each of these four newly identified hotspots, and the best-performing clone was selected for inoculation-density optimization and further fed-batch evaluation. Following optimization, this clone achieved a mean antibody titer of 1.172 ± 0.019 g/L in a 3-L bioreactor fed-batch culture. Collectively, these findings provide a set of productive genomic hotspots for site-specific integration and may facilitate the development of high-performance CHO cell lines for biopharmaceutical manufacturing.
Zitieren
APA
Sun, Y., Lei, Y., Yu, C., Zhao, Y., Qi, L., Zhang, Y., Wang, L., Yang, N., Zhang, K., An, J., & Wang, M. (2026). An integrated high-throughput strategy for discovering and validating productive genomic integration hotspots in CHO cells. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.2005695
Vancouver
Sun Y, Lei Y, Yu C, Zhao Y, Qi L, Zhang Y, et al. An integrated high-throughput strategy for discovering and validating productive genomic integration hotspots in CHO cells. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.2005695
BibTeX
@article{Sun2026,
author = {Sun, Yonghui and Lei, Yu and Yu, Chang and Zhao, Yue and Qi, Linlin and Zhang, Yue and Wang, Lixian and Yang, Nazi and Zhang, Kexin and An, Jingjing and Wang, Meng},
title = {An integrated high-throughput strategy for discovering and validating productive genomic integration hotspots in CHO cells},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.2005695}
}
EUVIMED